Philips is releasing its new EmboGuide tool for helping interventional radiologists to perform embolizations by visualizing tumors and feeder blood vessels. The software works with the company’s AlluraClarity interventional X-ray and XperCT Dual multiphase cone beam CT.
Imaging data is gathered before the procedure, and once the patient is on the operating table, live X-ray data is overlayed with planning information created prior to start. As catheters are snaked down the planned route, they can be easily tracked as they take the correct path and adjusted as necessary to follow the superimposed map.
From Philips:
See – EmboGuide leverages the ultra-low X-ray dose settings of Philips’ AlluraClarity interventional X-ray system and the fast, high quality imaging of the abdomen of XperCT Dual. XperCT Dual’s enhanced imaging technique (multiphase cone beam CT) offers high quality 3D images of lesions, with proven detection accuracy superior to conventional 2D angiographic imaging. It offers clinicians a better view of the treatment targets for informed decision making while performing the procedure. XperCT Dual is comparable to MRI, which is considered to be the ‘gold standard’ [1,2].
Reach – EmboGuide helps to define the tumor lesions and features automatic identification of blood vessels that feed the lesions. It detects more than twice as many tumor feeding arteries compared to conventional imaging methods (Digital Subtraction Angiography (DSA) [1]. This allows interventional radiologists to optimize the catheter locations for embolization and plan a route to them. During the administration of the embolization agent, EmboGuide accurately superimposes the planning information onto the interventional X-ray system’s live images to monitor the treatment progress and determine its endpoint [3-5].
Treat – “In the treatment of intermediate HCC, the integrated use of our embolic device with image guidance is vital for successful treatment,” said Mike Motion, BTG General Manager, Interventional Oncology. “As a leader in interventional oncology, we invest to improve the safety and efficacy of the procedure. Partnering with Philips has strengthened our ability to further develop this cohesive approach using DC Bead® and Philips’ EmboGuide with the ultimate objective of advancing interventional oncology.”
Video of the display screen showing off EmboGuide’s capabilities:
Press release: Philips expands interventional oncology portfolio with EmboGuide to see, reach and treat tumor lesions…